Cancer, Cachexia, Sarcopenia, Muscle injury
Conditions
Interventions
None listed
Sponsors
Feinstein Institutes for Medical Research
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: P: Animals suffering from cancer, cachexia, or sarcopenia/muscle injury that can be induced as cachexia-related symptoms or Cancer cell lines I: Intravascular injection, or direct injection into the region of cancer or sarcopenia/muscle injury in in vivo study with isolated mitochondria. Direct transplantation/co-culture in in vitro study with isolated mitochondria. O: biological or physiological measures of the cancer, cachexia, or sarcopenia/muscle injury S: RCT, other intervention studies, cohort studies, animal studies, cancer cell line studies 1. Studies published in peer-reviewed journals. 2. Studies published as research papers which enabled to obtain a full text. 3. Journals written in English.
Exclusion criteria
Exclusion criteria: 1. Studies that used a mesenchymal stem cell-mediated transfer of mitochondria as a transfer method
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biological or physiological measures of the cancer, cachexia, or sarcopenia/muscle injury | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety | — |
Countries
North America
Contacts
Public ContactKei Hayashida
Feinstein Institutes for Medical Research Laboratory for Critical Care Physiology
Outcome results
None listed